SUMMARY

                        Conflict is inevitable and confrontation mandatory if we are to resolve conflict with positive and proactive                         results.  Learn the four communication styles and the eight steps to meeting conflict with optimism and                         success.  Be able to recognize and deflect the Red Herring and remain in control even when you get your                         chain jerked!!                     

                     OBJECTIVES:

                        1.  Identify and disarm the Red Herring

                        2.  Remain assertive rather than aggressive (while keeping your sanity)

                        3.  Differentiate destructive arguments from constructive debate

1430-1500  BREAK

1500-1525  Case Study:  ATTACK OF THE CLONES

                        Christina Barron, MT(ASCP)SBB

                        American Red Cross, St Louis, MO

                    BIOGRAPHY:

                        Chris graduated from St. Louis University with a degree in Medical Tecnology.  She worked in the Blood

                        Banks of St. John's Mercy Medical Center, St Mary's Hospital, and Barnes Hospital.  Chri joined the

                        Reference Laboratory at the Missouri-Illinois Region American Red Cross in 1988.  She has held positions

                        as a Technologist, Lead Technologist, Manager, Change Control Administrator, and Technical Support

                        Specialist.

                    SUMMARY/OBJECTIVES:

                        The use of monoclonal reagents for blood typing has resulted in the discovery of new antigens, but has

                        also caused difficulties when Technologists are faced with discrepancies in the blood bank.  This

                        presentation will highlight several cases found in our laboratory and will compare various reagent

                        manufacturers and the clones used in their monoclonal reagents.

1525-1615  Presentation:  COMPARING AND CONTRASTING ANTIBODY DETECTION METHODS

                        Ann Steiner, MT(ASCP)SBB

                        Ortho Clinical Diagnostics, Ann Arbor, MI

                    BIOGRAPHY:

                        My current position is Blood Bank Technical Specialist for Ortho Diagnostics where I support gel manual

                        and automated testing.  Previously I was the supervisor of the Reference Laboratory at the University

                        of Michigan and I have served as the Chair of the AABB Committee on Reference Laboratories and the

                        Rare Donor File.

                    OBJECTIVES:

                        1.    List at least 3 serological results that may signify the need for an antibody identification study.

                        2.    List at least 3 variables that can affect the results of the pretransfusion antibody screen test (PTAS).

                        3.    List at least 4 of the goals of the PTAS.

                        4.    List at least 4 causes of a false positive or unreadable PTAS.

1615-1800    Reception/Vendor Exhibits

________________________________________________________________________________________

________________________________________________________________________________________

                        Dr. Lowell Tilzer

                        K.U. Medical Center, Kansas City, KS

                        BIOGRAPHY: 

                            Tilzer received his bachelor, MD, and PhD degrees, as well as his residency training at the University of

                            Kansas.  He served on the School of Medicine faculty until 1992.  Before returning to KU Medical Center,

                            he was CEO for the American Red Cross Southwest Blood Region.  Dr. Tilzer returned to the Kansas

                            University Medical Center in 2004 as professor of Pathology for the KU School of Medicine.  He serves

                            as Medical Director of the Clinical Laboratory and Chairman of the Department of Pathology and

                            Laboratory Medicine. 

                            Tilzer is co-author of the Laboratory Test Handbook, third edition, the second largest selling book in

                            laboratory medicine.  He has also published more than 50 articles in peer-reviewed journals.  His

                            accomplishments include being the first to implement bar coding for laboratory specimen process,

                            discovery of progesterone receptors in meningiomas and being the first to suggest progestin therapy for

                            treatment of inoperable meningiomas.  Tilzer also invented and patented novel techniques for

                            extracting DNA and RNA using gel barrier technology, which led to the founding of Isogene

                            Biotechnology. 

                        OBJECTIVES:

                            1.    Learn the adverse reactions due to:

                                    a)    Red Blood Cells

                                    b)    Platelets

                                    c)    Plasma 

                            2.    Using evidence based medicine, understand when to use the major blood components

                            3.    Use of alternatives to blood components in a bleeding patient

1420-1445  Case Study:  YOU ARE WHAT YOU EAT!  AN INTERESTING TTP/HUS CASE STUDY

                        Misty Fowler

                        Saint Luke's Hospital, Kansas City, MO

1445-1500  BREAK 

1500-1525  Case Study:  A SICKLE IN A PICKLE      

                        Julie Kirkegaard

                        Community Blood Center, Kansas City, MO

1525-1615  Presentation:  CHARLES DREW AND YOU:  THE VALUE OF DIRECTED DONATION 

                        Ruby Russell, Clinical Laboratory Scientist

                        Saint Luke's Hospital, Kansas City

                        BIOGRAPHY:

                            American Red Cross - Executive Board Member of the Charles Drew Program, Kansas City, MO

                            Clinical Laboratory Scientist 

                        INTRODUCTION:

                            Imagine yourself lying in a hospital bed needing a transfusion and you've just been told you have

                            formed your 4th alloantibody and your transfusion will have to wait.  This is the reality for some

                            sickle cell patients across the country.  So how does the blood service industry follow the new Healthy

                            People Initiatives for 2020 to "Prevent illness and disability related to blood disorders and the use of

                            blood products^"1?  The American Red Cross, Charles Drew Program, uses directed donations to improve

                            blood safety for patients with Sickle Cell Anemia. 

                        OBJECTIVES:

                            1.    Charles Drew Program Overview

                            2.    Directed Donation importance/impact

                            3.    Statistics for Charles Drew/Directed Donation

                            4.    Personal accounts:

                                    ο    Ruby Russell (Kansas City Charles Drew Board Member)

                                    ο    Earnestine Diamond (KCMO Charles Drew Board Member & oldest living sickle cell patient)

                                    ο    Rachel Young (Kansas City Charles Drew Board Member)

                            5.    How your organization/you can personally get involved